Literature DB >> 19359709

Developing and evaluating outcomes of an evidence-based protocol for the treatment of osteomyelitis in Stage IV pressure ulcers: a literature and wound electronic medical record database review.

Robert Rennert1, Michael Golinko, Alan Yan, Anna Flattau, Marjana Tomic-Canic, Harold Brem.   

Abstract

Osteomyelitis affects up to 32% of full-thickness pressure ulcers and increases treatment costs and the risk of systemic complications. Current diagnosis and treatment practices are variable. A literature and retrospective chart review, using a wound electronic medical record (WEMR), were conducted to develop an evidence-based protocol of care for treatment of osteomyelitis in pressure ulcers and to evaluate outcomes of care. The seven steps in the protocol of care include: 1) acknowledgment of osteomyelitis risk in patients with Stage IV pressure ulcers, 2) clinical evaluation for local or systemic signs of infection upon initial presentation, 3) radiographic evaluation (magnetic resonance imaging or bone scan), 4) surgical debridement to remove all nonviable tissue and/or scarred and infected bone, 5) obtaining pathology reports from sterile bone biopsy and deep microbial cultures, 6) targeted systemic antimicrobial therapy, and 7) tissue reconstruction following resolution of infection. WEMR data review (177 patients) identified 50 patients with osteomyelitis (prevalence 28%). Of those, 41 underwent 87 bone debridements for osteomyelitis. Eight (20%) patients experienced complications elated to treatment. Average time to discharge following debridement was 4.3 +/- 5.7 days and 76% of wounds with more than two consecutive WEMR entries showed a decrease in area at their final visit. The outcomes observed are encouraging and the WEMR facilitates implementation and evaluation of the treatment protocol. Ongoing data acquisition will help assess outcomes and refine the current management protocol and should improve diagnosis and care.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19359709

Source DB:  PubMed          Journal:  Ostomy Wound Manage        ISSN: 0889-5899            Impact factor:   2.629


  7 in total

Review 1.  Osteomyelitis Complicating Sacral Pressure Ulcers: Whether or Not to Treat With Antibiotic Therapy.

Authors:  Darren Wong; Paul Holtom; Brad Spellberg
Journal:  Clin Infect Dis       Date:  2019-01-07       Impact factor: 9.079

Review 2.  Review of the Current Management of Pressure Ulcers.

Authors:  Tatiana V Boyko; Michael T Longaker; George P Yang
Journal:  Adv Wound Care (New Rochelle)       Date:  2018-02-01       Impact factor: 4.730

3.  Diagnosis and Management of Osteomyelitis Associated With Stage 4 Pressure Ulcers: Report of a Query to the Emerging Infections Network of the Infectious Diseases Society of America.

Authors:  Anjum S Kaka; Susan E Beekmann; Amy Gravely; Gregory A Filice; Philip M Polgreen; James R Johnson
Journal:  Open Forum Infect Dis       Date:  2019-11-01       Impact factor: 3.835

4.  Support surfaces for treating pressure ulcers.

Authors:  Elizabeth McInnes; Asmara Jammali-Blasi; Sally Em Bell-Syer; Vannessa Leung
Journal:  Cochrane Database Syst Rev       Date:  2018-10-11

5.  Pressure Ulcer-Related Pelvic Osteomyelitis: A Neglected Disease?

Authors:  Phani Bodavula; Stephen Y Liang; Jiami Wu; Paige VanTassell; Jonas Marschall
Journal:  Open Forum Infect Dis       Date:  2015-08-06       Impact factor: 3.835

6.  Validation of two case definitions to identify pressure ulcers using hospital administrative data.

Authors:  Chester Ho; Jason Jiang; Cathy A Eastwood; Holly Wong; Brittany Weaver; Hude Quan
Journal:  BMJ Open       Date:  2017-08-28       Impact factor: 2.692

7.  Pressure ulcer-related pelvic osteomyelitis: evaluation of a two-stage surgical strategy (debridement, negative pressure therapy and flap coverage) with prolonged antimicrobial therapy.

Authors:  Johan Andrianasolo; Tristan Ferry; Fabien Boucher; Joseph Chateau; Hristo Shipkov; Fatiha Daoud; Evelyne Braun; Claire Triffault-Fillit; Thomas Perpoint; Frédéric Laurent; Alain-Ali Mojallal; Christian Chidiac; Florent Valour
Journal:  BMC Infect Dis       Date:  2018-04-10       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.